Predicting Intensive Care Unit Admission for COVID-19 Patients from Laboratory Results.
Basmah M Azad AllarakiaHattan S GattanRawan H AbdeenBassam M Al-AhmadiAbdullah F ShaterMohammed B BazaidOmar W AlthomaliAbdulrahman S BazaidPublished in: Disease markers (2022)
Trends in routine laboratory tests, such as high white blood cell and low platelet counts, correlate with COVID-19-related intensive care unit (ICU) admissions. Other related biomarkers include elevated troponin, alanine aminotransferase, and aspartate transaminase levels (liver function tests). To this end, the aim of this study was to investigate the effect of changes in laboratory test parameters on ward-based and ICU COVID-19 patients. A total of 280 COVID-19 patients were included in the study and were divided based on admission status into ICU (37) or ward (243) patients. ICU admission correlated significantly with higher levels of several tested parameters, including lactate dehydrogenase, creatinine, D-dimer, creatine kinase, white blood cell count, and neutrophil count. In conclusion, routine laboratory tests offer an indication of which COVID-19 patients are most likely to be admitted to the ICU. These associations can assist healthcare providers in addressing the needs of patients who are at risk of COVID-19 complications.
Keyphrases
- intensive care unit
- sars cov
- mechanical ventilation
- end stage renal disease
- healthcare
- emergency department
- coronavirus disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- prognostic factors
- stem cells
- cell therapy
- risk factors
- clinical practice
- patient reported outcomes
- respiratory syndrome coronavirus
- drug induced
- health information
- social media